New prostate drug tested in healthy volunteers
NCT ID NCT06110923
First seen Jan 15, 2026 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This early-stage study tested a new drug called CKD-846 in 31 healthy men to see how the body processes it and if it is safe. The drug is being developed for benign prostate hypertrophy (BPH), a common condition where the prostate gland enlarges. The study did not treat any disease but gathered important information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.